Supplemental Balance Sheet Information (Tables)

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Accrued Expenses

Accrued expenses consisted of the following:

	March 31, 2022		December 31, 2021
	(In thousands)
Employee compensation and benefits	$	7,750	$	11,737
Research and development expenses		12,975		13,744
Current portion of liability related to the sale of future royalties		433		273
Professional services and other		5,032		5,023
Accrued expenses	$	26,190	$	30,777